Level Chart

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Trikafta / Kaftrio Revenue is at a current level of 2.333B, up from 2.274B last quarter and up from 2.022B one year ago. This is a change of 2.59% from last quarter and 15.42% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 2.333B
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:49 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 53.54%
Value from Last Quarter 2.274B
Change from Last Quarter 2.59%
Value from 1 Year Ago 2.022B
Change from 1 Year Ago 15.42%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2023 2.333B
September 30, 2023 2.274B
June 30, 2023 2.240B
March 31, 2023 2.097B
December 31, 2022 2.022B
September 30, 2022 2.010B
June 30, 2022 1.893B
March 31, 2022 1.762B
December 31, 2021 1.693B
Date Value
September 30, 2021 1.556B
June 30, 2021 1.256B
March 31, 2021 1.193B
December 31, 2020 1.091B
September 30, 2020 960.00M
June 30, 2020 918.00M
March 31, 2020 895.00M
December 31, 2019 420.00M

Basic Info

Vertex Pharmaceuticals Inc (VRTX) - Trikafta / Kaftrio Revenue is at a current level of 2.333B, up from 2.274B last quarter and up from 2.022B one year ago. This is a change of 2.59% from last quarter and 15.42% from one year ago.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 2.333B
Latest Period Dec 2023
Last Updated Apr 30 2024, 08:49 EDT
Next Release Jul 31 2024, 08:30 EDT (E)
Average Growth Rate 53.54%
Value from Last Quarter 2.274B
Change from Last Quarter 2.59%
Value from 1 Year Ago 2.022B
Change from 1 Year Ago 15.42%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
VRTX Vertex Pharmaceuticals Inc 0.23%